Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support


Neurorehabilitation Devices Market size was valued at USD 2.49 Billion in 2022 and is poised to grow from USD 2.89 Billion in 2023 to USD 9.40 Billion by 2031, at a CAGR of 15.9% during the forecast period (2024-2031).

The neurorehabilitation devices market is characterized by a competitive landscape with several key players striving to develop innovative solutions for neurological rehabilitation. These companies compete in terms of product offerings, technological advancements, geographic presence, and market share. While the specific competitive landscape may evolve over time, as of my knowledge cutoff in September 2021, there were several notable companies leading the market. The competitive landscape is dynamic, with new entrants and startups also emerging with innovative technologies and approaches. Additionally, partnerships, collaborations, and acquisitions among companies further shape the competitive dynamics in the market. As the demand for neurorehabilitation devices continues to grow, competition among players will likely intensify, driving further innovation and advancements in the field. It is important to refer to the latest market reports and industry updates to obtain the most up-to-date information on the competitive landscape in the neurorehabilitation devices market. 'Medtronic (US)', 'Abbott Laboratories (US)', 'Boston Scientific Corporation (US)', 'Stryker Corporation (US)', 'Smith & Nephew plc (UK)', 'Bioness Inc. (US)', 'Hocoma AG (Switzerland)', 'St. Jude Medical (US)', 'Ekso Bionics Holdings, Inc. (US)', 'Bioxtreme Robotics Rehabilitation (Italy)', 'ReWalk Robotics Ltd. (Israel)', 'Neurostyle Pte. Ltd. (Singapore)', 'Kinova Robotics (Canada)', 'Neuro Rehab VR (US)', 'Tyromotion GmbH (Austria)', 'Neofect (South Korea)', 'Enraf-Nonius (Netherlands)', 'Hobbs Rehabilitation (UK)', 'Motek Medical B.V. (Netherlands)', 'Biodex Medical Systems, Inc. (US)'

One driver of the neurorehabilitation devices market is the continuous advancements in technology. In recent years, there have been significant developments in areas such as robotics, virtual reality, wearable sensors, and brain-computer interfaces. These advancements have enabled the development of more sophisticated and effective neurorehabilitation devices, providing targeted therapies and personalized rehabilitation solutions for patients. For example, robotic exoskeletons like the EksoGT by Ekso Bionics and the ReWalk system by ReWalk Robotics are designed to assist individuals with mobility impairments in walking and improving their motor skills.

Tele-rehabilitation: A key trend in the neurorehabilitation devices market is the adoption of tele-rehabilitation solutions. Tele-rehabilitation allows patients to receive rehabilitation services remotely, using technology to connect with healthcare professionals and access therapy sessions from their homes. This trend has gained momentum, especially during the COVID-19 pandemic when in-person rehabilitation services faced limitations. Tele-rehabilitation offers convenience, accessibility, and the potential for continuous monitoring and personalized care.

The dominating region in the neurorehabilitation devices market is North America. North America has a well-established healthcare infrastructure, advanced technological capabilities, and a high level of awareness regarding neurological disorders and their rehabilitation. The region benefits from significant investments in research and development, leading to the development of innovative neurorehabilitation devices. Moreover, favorable reimbursement policies and a strong presence of key market players contribute to North America's dominance in the neurorehabilitation devices market.

Feedback From Our Clients

Global Neurorehabilitation Devices Market

Product ID: SQMIG35A2377